-
2023 CHS Annual Report
Please CLICK HERE to access the 2023 CHS Annual Report. Should you want to consult the complete Financial Statements, you can do so by clicking...
-
Canadian Hemophilia Society’s tribute to Dr. Victor S. Blanchette
It is with much sadness that we report that, after a long and courageous battle with cancer, Dr. Victor Stanley Blanchette passed away on April...
-
New shared decision-making tool (SDM) by the World Federation of Hemophilia
The World Federation of Hemophilia SDM Tool is an interactive decision-support system designed to facilitate discussions regarding treatment options between people with hemophilia A or...
-
Patient satisfaction survey
The Canadian bleeding disorder treatment centres participed in a rigorous self-assessment of their services from November 2022 to February 2023. IT IS NOW TIME TO...
-
Important survey about hemophilia B gene therapy – THE CLOCK IS TICKING!
The 1st gene therapy for hemophilia B (factor IX deficiency) is currently undergoing an evaluation by Canadian health authorities. This review will determine whether or...